Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Both hold potential in different domains: Bitcoin as peer-to-peer money and blockchain as a platform for diverse, programmable applications.
28,588 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Global markets slide as diplomatic talks stall and tensions rise around the Strait of Hormuz, driving a broad sell-of...
Markets confront a paradox: AI’s potential is immense, but real-world adoption is uneven. Household budgets and inves...
A sharp escalation in the Middle East sees Iran strike U.S. military bases, triggering a broad market selloff and a s...
The chef’s colicchio return tech story highlights how nontraditional investors are finding outsized gains in niche te...
Cardano confronts a pivotal treasury vote with Input Output seeking 46.8M ADA for 2026. cardano founder warns network...
A decade-long income lure from QYLD masks a sizable NAV erosion. The ETF's NAV has declined about 35% since its 2013 ...
Fidelity has alerted owners of 500-stock funds that the S&P 500 is dominated by a small group of mega-caps, raising q...
A cybersecurity-focused ETF bearing the infamous ticker SPAM is delivering strong 2026 gains, tripling the S&P 500's ...
A rare, inside look at Kevin Warsh’s thinking on the Fed, told by those closest to him during the crisis and today’s ...
Analysts reveal a skewed distribution in Pi token ownership, highlighting a small number of mega-holders and a vast m...
A newlywed couple with a sizable debt and a landlord’s portfolio faces a blunt financial question on The Ramsey Show:...